Neuramancer AI Solutions: Pre-Seed

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.